Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
Ther Adv Neurol Disord. 2024 Apr 17;17:17562864241243186. doi: 10.1177/17562864241243186. eCollection 2024.
Ther Adv Neurol Disord. 2024.
PMID: 38638673
Free PMC article.
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Howard JF Jr, Bresch S, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Boroojerdi B, Brock M, de la Borderie G, Duda PW, Lowcock R, Vanderkelen M, Leite MI; RAISE Study Team.
Howard JF Jr, et al. Among authors: vanderkelen m.
Lancet Neurol. 2023 May;22(5):395-406. doi: 10.1016/S1474-4422(23)00080-7.
Lancet Neurol. 2023.
PMID: 37059508
Clinical Trial.
Item in Clipboard
Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial.
Mammen AL, Amato AA, Dimachkie MM, Chinoy H, Hussain Y, Lilleker JB, Pinal-Fernandez I, Allenbach Y, Boroojerdi B, Vanderkelen M, Delicha EM, Koendgen H, Farzaneh-Far R, Duda PW, Sayegh C, Benveniste O.
Mammen AL, et al. Among authors: vanderkelen m.
Lancet Rheumatol. 2023 Feb;5(2):e67-e76. doi: 10.1016/s2665-9913(23)00003-6. Epub 2023 Jan 24.
Lancet Rheumatol. 2023.
PMID: 36923454
Free PMC article.
Item in Clipboard
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
Miller PD, Adachi JD, Albergaria BH, Cheung AM, Chines AA, Gielen E, Langdahl BL, Miyauchi A, Oates M, Reid IR, Santiago NR, Vanderkelen M, Wang Z, Yu Z.
Miller PD, et al. Among authors: vanderkelen m.
J Bone Miner Res. 2022 Aug;37(8):1437-1445. doi: 10.1002/jbmr.4563. Epub 2022 May 20.
J Bone Miner Res. 2022.
PMID: 35466448
Free PMC article.
Clinical Trial.
Item in Clipboard
Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.
Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Kimball AB, Cush JJ, Cooney M, Shaughnessy L, Vanderkelen M, Förger F.
Clowse MEB, et al. Among authors: vanderkelen m.
Arthritis Rheumatol. 2018 Sep;70(9):1399-1407. doi: 10.1002/art.40508. Epub 2018 Jul 22.
Arthritis Rheumatol. 2018.
PMID: 29623679
Free PMC article.
Item in Clipboard
Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK.
Abbasi A, Fryk H, Rudnik J, White R, Vanderkelen M, Scowcroft A, Bonar K.
Abbasi A, et al. Among authors: vanderkelen m.
Neurol Sci. 2024 May;45(5):2321-2324. doi: 10.1007/s10072-024-07336-8. Epub 2024 Jan 25.
Neurol Sci. 2024.
PMID: 38270730
Item in Clipboard
Urinary plasma protein patterns in acute prostatitis.
Everaert K, Delanghe J, Vanderkelen M, Cornelis K, De Wachter S, Viaene A, De Ruyck E, Clarysse B, Oosterlinck W.
Everaert K, et al. Among authors: vanderkelen m.
Clin Chem Lab Med. 2003 Jan;41(1):79-84. doi: 10.1515/CCLM.2003.014.
Clin Chem Lab Med. 2003.
PMID: 12636054
Item in Clipboard
Cite
Cite